Antipsychotic treatment in schizophrenia: atypical options and NICE guidance

By Mortimer A.M.  

European Psychiatry, Vol. 18, Iss. 5, 2003-08 ,pp. : 209-219

Elsevier

Access to resources Recommend Favorite

Patient satisfaction after switching from conventional to new atypical antipsychotics in schizophrenia

By Bartkó György   Váradi Hedvig   Simon Lajos   Linka Emese   Tüske Tamás   Szabó Tibor   Sántha Judit  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-03 ,pp. : 9-14

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

By Wittorf Andreas  

Archives of Clinical Neuropsychology, Vol. 23, Iss. 3, 2008-05 ,pp. : 271-282

Oxford University Press

Access to resources Recommend Favorite

Patients' perceptions of their involvement in decision making about antipsychotic drug choice as outlined in the NICE guidance on the use of atypical antipsychotics in schizophrenia

By Paton Carol   Esop Radia  

Journal of Mental Health, Vol. 14, Iss. 3, 2005-06 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite

Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent

By Heitmiller D.R.   Nopoulos P.C.   Andreasen N.C.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite